Trial Profile
A pharmacokinetic study of IRT-103 for the treatment of Crohn's disease both in children and adults
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 Jun 2023
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics
- 11 Aug 2015 New trial record